Tag: Obesity

Obesity linked to what’s on local restaurant menus

Food deserts have long been a concern for health experts, as they refer to areas where residents lack

Readers react to ancient hunting tactics, dog obesity and narwhal play

The hunters likely used their knowledge of the landscape, the movements of the horses, and their own physical

Early-life weight gain boosts adult height without increasing obesity risk, study shows

Childhood undernutrition is a critical issue that can have long-lasting effects on a child's health and development. A

Employers Reluctant To Cover Obesity Meds, Lower Costs May Change This

Employers in the United States are still hesitant to cover glucagon-like peptide-1 (GLP-1) drugs for weight loss, according

Having ADHD And Living In A Smaller City Might Increase Obesity Risk: Study

ADHD and Obesity: How Urban Living Conditions Impact Health Photo: Lino Mirgeler/dpa (Photo by Lino Mirgeler/picture alliance via

Novo Nordisk cuts forecasts after replica obesity drugs hit US take-up

Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this

America’s Fattest Cities Revealed In Shocking Obesity Rate Update

America's Fattest and Skinniest Cities Revealed: Shocking Obesity Rates According to recent studies, the top 10 fattest cities

NIH internships, osteoarthritis, obesity tracker

Here is a look at some of the top health and medicine stories making headlines today: CANCELLED INTERNSHIP

Novo Nordisk to sell obesity drug Wegovy direct to patients at lower price

Novo Nordisk has announced that it will be offering its obesity drug Wegovy directly to patients at a

Jay Bhattacharya, Medicaid cuts, obesity in 2050

The rise of infectious diseases in pets is becoming a growing concern, mirroring the increase in human diseases.

Biocon Launches Diabetes, Obesity Management Drug In UK

New Delhi: Leading biotechnology company Biocon has recently introduced a groundbreaking product in the UK for managing diabetes

Market pressure seen as fueling too much weight loss in new obesity drugs

Eli Lilly's next-generation obesity drug, known as retatrutide, is causing unexpected outcomes in ongoing trials. Instead of struggling